ArticleMemorias do Instituto Oswaldo Cruz2021
Do the new triatomine species pose new challenges or strategies for monitoring Chagas disease? An overview from 1979-2021.
Article in Memorias do Instituto Oswaldo Cruz, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 39 citations in OpenAlex.
- Spatial overlap of palm trees and triatomine distribution areas in Brazil.Scientific reports · 2026Article
- Viability of Trypanosoma cruzi in Triatoma pallidipennis Post-mortem.Acta parasitologica · 2026Article
- Coexistence of monogamy and polygyny in Triatoma infestans: fine-scale genealogical structure reveals complex social structures within domestic colonies in the Bolivian ChacoMemorias do Instituto Oswaldo Cruz · 2026Article
- First record of Triatoma vitticeps (Hemiptera, Reduviidae) colonising a brick house in an urban area of a devastated Atlantic Forest fragment in Rio de Janeiro State, Brazil.Memorias do Instituto Oswaldo Cruz · 2026Article
- Seroepidemiological survey and seropositivity rate for Trypanosoma cruzi infection in a community-based cardiac screening initiative in Feira de Santana, Bahia, Brazil.PLoS neglected tropical diseases · 2026Article
- Rhodnius prolixus impairs Trypanosoma cruzi growth through cold-seeking behavioral thermoregulation.PLoS neglected tropical diseases · 2025Article
- Endemic potential of Chagas disease in the U.S. southwest: updated surveillance of infected Triatomines from the U.S.-Mexico border region.Epidemiology and infection · 2025Article
- Comparative Analysis of Vectorial Capacity AmongMicroorganisms · 2025Article
- The mitogenome of Triatoma brasiliensis brasiliensis (Hemiptera: Reduviidae), the main Chagas disease vector in the semi-arid region of northeastern Brazil.Parasites & vectors · 2025Article
- Hybrids versus parental species: insights from wing phenotype similarities and differences in triatomine insects.Frontiers in insect science · 2025Article
- Triatoma venosa and Panstrongylus geniculatus challenge the certification of interruption of vectorial Trypanosoma cruzi transmission by Rhodnius prolixus in eastern Colombia.PLoS neglected tropical diseases · 2025Article
- Transmission ecology of Trypanosoma cruzi by Rhodnius prolixus (Reduviidae: Triatominae) infesting palm-tree species in the Colombian Orinoco, indicates risks to human populations.PLoS neglected tropical diseases · 2024Article
- First report of mixed Trypanosoma cruzi discrete typing units infection in Triatoma phyllosoma in the peri-urban environment of Oaxaca, Mexico.Revista da Sociedade Brasileira de Medicina Tropical · 2024Article
- Article
- The risk of vector transmission of Trypanosoma cruzi remains high in the State of Paraná.Memorias do Instituto Oswaldo Cruz · 2024Article
- Entomological indicators and food sources of triatomines in the Brazilian semi-arid region.Revista da Sociedade Brasileira de Medicina Tropical · 2024Article
- Triatomines in the city: A study of Rhodnius neglectus in Jaboticabal, São Paulo, Brazil, and its epidemiological implications.Revista da Sociedade Brasileira de Medicina Tropical · 2024Article
- Experimental Hybrids of theMicroorganisms · 2023Article
- Characterization of External Female Genitalia in FiveTropical medicine and infectious disease · 2023Article
- Dichotomous Keys Based on Cytogenetic Data for Triatomines Reported in Brazilian Regions with Outbreaks of Orally Transmitted Chagas Disease (Pernambuco and Rio Grande Do Norte).Tropical medicine and infectious disease · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chagas disease persists as one of the most important, and yet most neglected, diseases in the world, and several changes in its epidemiological aspects have been recorded since its discovery. Currently, some of the most relevant changes are related to: (i) the reduction in the incidence of the endemic due to the control of the most important vectors, Triatoma infestans and Rhodnius prolixus, in many countries; (ii) the migration of human populations spreading cases of the disease throughout the world, from endemic to non-endemic areas, transforming Chagas disease into a global threat; and (iii) new acute cases and deaths caused by oral transmission, especially in the north of Brazil. Despite the reduction in the number of cases, new challenges need to be responded to, including monitoring and control activities aiming to prevent house infestation by the secondary vectors from occurring. In 1979, Lent & Wygodzinsky(1) published the most complete review of the subfamily Triatominae, encompassing 111 recognised species in the taxon. Forty-two years later, 46 new species and one subspecies have been described or revalidated. Here we summarise the new species and contextualise them regarding their ecology, epidemiologic importance, and the obstacles they pose to the control of Chagas disease around the world.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.